Small Molecules
11 October 2017
Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of Acne10 October 2017
Abide Therapeutics Announces Dosing of First Subject in Phase 1b Study of ABX-1431 in Patients with Neuromyelitis Optica (NMO)10 October 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids10 October 2017
Arsanis Presents Phase 1 and Preclinical Pharmacokinetic Data on Lead Product Candidate, ASN100, at IDWeek™ 201710 October 2017
GNI Group Announces Clearance of Investigational New Drug (IND) by FDA for F351 Clinical Trials in the Treatment of Liver Fibrosis10 October 2017
OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines9 October 2017
EDO announces next milestone for tinostamustine (EDO-S101) as first-in-human solid tumor study begins4 October 2017
Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Meniere’s Disease4 October 2017
ImmunoMet Announces Initiation of Phase 1 Clinical Study of IM156, an OXPHOS Inhibitor, in Patients with Solid Tumors4 October 2017
RG7916 Increased SMN Protein Production in SUNFISH Clinical Trial in Patients with Type 2/3 Spinal Muscular Atrophy4 October 2017
Motif Bio Announces Positive Topline Results for iclaprim in the REVIVE-2 Phase 3 StudyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports